Stocktoria
Sintx Technologies, Inc. SINT
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-02-11
Sintx Technologies, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $2.9M | $2.6M | $1.6M | $606,000 | $594,000 | $689,000 | $95,000 | $11.2M | $15.2M |
| Gross profit | $461,000 | $2.1M | $1.8M | $1.3M | $157,000 | $119,000 | $138,000 | $39,000 | $4.9M | $11.4M |
| R&D expense | $4.6M | $5.2M | $8.7M | $6.5M | $5.9M | $4.8M | $3.4M | $3.0M | $3.5M | $6.3M |
| Operating income | -$10.7M | -$14.0M | -$13.4M | -$11.3M | -$10.6M | -$8.5M | -$6.6M | -$13.1M | -$7.5M | -$11.5M |
| Net income | -$10.4M | -$11.0M | -$8.3M | -$12.0M | -$9.3M | -$7.0M | -$4.8M | -$8.7M | -$9.3M | -$14.8M |
| EPS (diluted) | $-6.16 | $-15.19 | $-624.47 | $-60.81 | $-39.91 | $-1.08 | $-5.69 | $-76.73 | — | — |
| Operating cash flow | -$8.6M | -$8.6M | -$14.1M | -$10.3M | -$10.1M | -$9.1M | -$6.4M | -$9.3M | -$7.1M | -$7.2M |
| Free cash flow | -$8.8M | -$9.3M | -$14.6M | -$11.7M | -$13.9M | -$9.5M | -$6.6M | -$9.4M | -$7.1M | -$7.8M |
| Cash & equivalents | $4.1M | $3.6M | $3.3M | $6.2M | $14.3M | $25.4M | $1.8M | $5.4M | $539,000 | $6.9M |
| Inventory | $825,000 | $502,000 | $888,000 | $737,000 | $597,000 | $487,000 | $639,000 | $676,000 | $675,000 | $7.2M |
| Total assets | $9.5M | $9.4M | $15.4M | $15.8M | $21.8M | $30.4M | $9.1M | $11.5M | $14.6M | $26.3M |
| Total liabilities | $6.6M | $5.5M | $6.6M | $10.1M | $4.6M | $4.6M | $3.9M | $3.1M | $9.2M | $15.0M |
| Shareholders' equity | $2.9M | $3.9M | $8.8M | $5.7M | $17.2M | $25.8M | $5.2M | $8.4M | $5.4M | $11.2M |
Growth · year-over-year · Revenue CAGR -26%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -64.7% | +9.9% | +68.3% | +157.6% | +2.0% | -13.8% | +625.3% | -99.2% | -26.3% | -21.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.